Introduction - the problem:We are at the dawn of a new era: the omic era. Genomics – the analysis of the inherited gene set of each individual is already an advanced technology broadly applied in population-wide studies and entered public life. The next level of ‘omic’ technologies is advancing,...
Introduction - the problem:Atlanpole Biotherapies is an interregional cluster, covering the regions of Pays de la Loire, Bretagne, and Centre Val de Loire, which was recognised and certified by the Ministry of Industry in July 2005.
Atlanpole Biotherapies coordinates the work of laboratories, companies and platforms for a public-private complete,...
Introduction - the problem:Dynamic Biosensors is a young biotech company based in Munich, Germany, focused on the development and marketing of our pioneering and award-winning switchSENSE® technology for molecular interaction analysis. We provide solutions to academic and industry partners in the areas of biophysical analysis and drug discovery.
Our just-launched...
Introduction - the problem:Current medicine too often loses the fight against civilization diseases. Type 2 diabetes, arterial hypertension, coronary heart disease, cancer, and depression are individuals diseases that dominate in the offices of Polish doctors. At the same time, cardiovascular diseases and neoplastic causes of death in more than...